Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study
Hexiang Peng, Siyue Wang, Mengying Wang, et al.
Metabolism (2022) Vol. 133, pp. 155220-155220
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
Yuan-ye Qiu, Jing Zhang, Fanyi Zeng, et al.
Pharmacological Research (2023) Vol. 192, pp. 106786-106786
Open Access | Times Cited: 102
Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges
Michail Kokkorakis, Chrysoula Boutari, Michael A. Hill, et al.
Metabolism (2024) Vol. 154, pp. 155835-155835
Open Access | Times Cited: 79
From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need
Michail Kokkorakis, Chrysoula Boutari, Niki Katsiki, et al.
Metabolism (2023) Vol. 147, pp. 155664-155664
Open Access | Times Cited: 42
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases
Reddemma Sandireddy, Suganya Sakthivel, Priyanka Gupta, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 24
Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic
Guocheng Rao, Xi Peng, Xinqiong Li, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 24
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
О. М. Драпкина, А. V. Kontsevaya, А. М. Калинина, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 23, Iss. 3, pp. 3696-3696
Open Access | Times Cited: 15
New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk
Marija Branković, Marija Dukić, Tijana Gmizić, et al.
Diagnostics (2024) Vol. 14, Iss. 2, pp. 229-229
Open Access | Times Cited: 11
Differing genetic variants associated with liver fat and their contrasting relationships with cardiovascular diseases and cancer
Altayeb Ahmed, Madeleine Cule, Jimmy D. Bell, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 921-929
Open Access | Times Cited: 11
Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease
Niki Katsiki, Genovefa Kolovou, Michal Vrablı́k
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access | Times Cited: 1
Non‐alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study
Ningyuan Liu, Ge Wang, Chao Liu, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 2, pp. 365-376
Closed Access | Times Cited: 31
Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery
Michail Kokkorakis, Angeliki Katsarou, Niki Katsiki, et al.
Metabolism (2023) Vol. 148, pp. 155689-155689
Open Access | Times Cited: 21
Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases
Zhenqiu Liu, Chen Suo, Hong Fan, et al.
Metabolism (2022) Vol. 135, pp. 155270-155270
Closed Access | Times Cited: 26
Association between the gut microbiota and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study
Yu Li, Xifeng Liang, Yaning Lyu, et al.
Digestive and Liver Disease (2023) Vol. 55, Iss. 11, pp. 1464-1471
Open Access | Times Cited: 15
Matrix Metalloproteinase and Aortic Aneurysm: A Two-sample Mendelian Randomization Study
Tao Qin, Jiankai Zhong, Pinglan Li, et al.
Annals of Vascular Surgery (2024) Vol. 105, pp. 227-235
Closed Access | Times Cited: 5
Causal relationship between particulate matter 2.5 and hypothyroidism: A two-sample Mendelian randomization study
Yuning Zhang, Shouzheng Liu, Yunwen Wang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 22
Identification of biomarkers associated with coronary artery disease and non-alcoholic fatty liver disease by bioinformatics analysis and machine learning
Chuan Lu, Mei Han, Qiqi Ma, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
An insight on the additive impact of type 2 diabetes mellitus and nonalcoholic fatty liver disease on cardiovascular consequences
Monika Bhardwaj, Papiya Mitra Mazumder
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Exploring the silent connection: unveiling the intricate relationship between gastroesophageal reflux disease and sleep apnea syndrome
Junming Wang, Pengfei Wang, Jiang Lv, et al.
Human Genomics (2025) Vol. 19, Iss. 1
Open Access
Trends and Disparities in Cardiovascular Disease in US Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease
Yanbing Zhang, Xinge Zhang, Chuiguo Huang, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 956-956
Open Access
Potential Causal Association between Elevated Gamma-Glutamyl Transferase Level and Stroke: A Two-Sample Mendelian Randomization Study
Young Lee, Je Hyun Seo
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1592-1592
Open Access | Times Cited: 10
Investigating the shared genetic architecture between schizophrenia and body mass index
Yuefeng Yu, Yanqi Fu, Yuetian Yu, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 6, pp. 2312-2319
Closed Access | Times Cited: 9
Skewness in Body fat Distribution Pattern Links to Specific Cardiometabolic Disease Risk Profiles
Jennifer Linge, Bertrand Cariou, Ian J. Neeland, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 3, pp. 783-791
Open Access | Times Cited: 9
The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases
Jiuguo Lin, Jiaojiao Wang, Jian Fang, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 12, pp. 1695-1719
Closed Access | Times Cited: 3
Association of serum 25-hydroxyvitamin D levels, vitamin D-binding protein levels, and diabetes mellitus: Two-sample Mendelian randomization
Xu Zhao, Bo Li, Li Xiao, et al.
Medicine (2024) Vol. 103, Iss. 20, pp. e38219-e38219
Open Access | Times Cited: 3
Shared genetic architecture and causal relationship between liver and heart disease
Ziyi Fang, Sixiang Jia, Xuanting Mou, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109431-109431
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top